Comments on: “Effectiveness of amivantamab compared with real-world therapies in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations post platinum-based chemotherapy”

Journal of the Formosan Medical Association 2026 Open access

Read full text

Authors: Wenyan Zhu, Mingqiu Mei

DOI: 10.1016/j.jfma.2026.04.116

Cited by: 1

References: 2

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Advanced Causal Inference Techniques Statistical Methods in Clinical Trials

References 2